nodes	percent_of_prediction	percent_of_DWPC	metapath
Aztreonam—Serum creatinine increased—Thalidomide—leprosy	0.0463	0.0463	CcSEcCtD
Aztreonam—Petechiae—Thalidomide—leprosy	0.0346	0.0346	CcSEcCtD
Aztreonam—Leukocytosis—Thalidomide—leprosy	0.0303	0.0303	CcSEcCtD
Aztreonam—Candida infection—Thalidomide—leprosy	0.0272	0.0272	CcSEcCtD
Aztreonam—Tinnitus—Dapsone—leprosy	0.0261	0.0261	CcSEcCtD
Aztreonam—Erythema—Dapsone—leprosy	0.0243	0.0243	CcSEcCtD
Aztreonam—Thrombophlebitis—Thalidomide—leprosy	0.0239	0.0239	CcSEcCtD
Aztreonam—Vascular purpura—Thalidomide—leprosy	0.0231	0.0231	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Thalidomide—leprosy	0.0219	0.0219	CcSEcCtD
Aztreonam—Vertigo—Dapsone—leprosy	0.0219	0.0219	CcSEcCtD
Aztreonam—Purpura—Thalidomide—leprosy	0.0215	0.0215	CcSEcCtD
Aztreonam—Cough—Dapsone—leprosy	0.0212	0.0212	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.0207	0.0207	CcSEcCtD
Aztreonam—Diplopia—Thalidomide—leprosy	0.0207	0.0207	CcSEcCtD
Aztreonam—Blood creatinine increased—Thalidomide—leprosy	0.0194	0.0194	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Thalidomide—leprosy	0.0186	0.0186	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Thalidomide—leprosy	0.0186	0.0186	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Thalidomide—leprosy	0.0182	0.0182	CcSEcCtD
Aztreonam—Abdominal distension—Thalidomide—leprosy	0.018	0.018	CcSEcCtD
Aztreonam—Insomnia—Dapsone—leprosy	0.018	0.018	CcSEcCtD
Aztreonam—Eosinophilia—Thalidomide—leprosy	0.0177	0.0177	CcSEcCtD
Aztreonam—Bronchospasm—Thalidomide—leprosy	0.0176	0.0176	CcSEcCtD
Aztreonam—Pancytopenia—Thalidomide—leprosy	0.017	0.017	CcSEcCtD
Aztreonam—Neutropenia—Thalidomide—leprosy	0.0167	0.0167	CcSEcCtD
Aztreonam—Gastrointestinal pain—Dapsone—leprosy	0.0162	0.0162	CcSEcCtD
Aztreonam—Abdominal pain—Dapsone—leprosy	0.0157	0.0157	CcSEcCtD
Aztreonam—Body temperature increased—Dapsone—leprosy	0.0157	0.0157	CcSEcCtD
Aztreonam—Stomatitis—Thalidomide—leprosy	0.0155	0.0155	CcSEcCtD
Aztreonam—Hepatitis—Thalidomide—leprosy	0.0143	0.0143	CcSEcCtD
Aztreonam—Erythema multiforme—Thalidomide—leprosy	0.0135	0.0135	CcSEcCtD
Aztreonam—Tinnitus—Thalidomide—leprosy	0.0133	0.0133	CcSEcCtD
Aztreonam—Vomiting—Dapsone—leprosy	0.0126	0.0126	CcSEcCtD
Aztreonam—Headache—Dapsone—leprosy	0.0124	0.0124	CcSEcCtD
Aztreonam—Dysgeusia—Thalidomide—leprosy	0.0122	0.0122	CcSEcCtD
Aztreonam—Nausea—Dapsone—leprosy	0.0118	0.0118	CcSEcCtD
Aztreonam—Ill-defined disorder—Thalidomide—leprosy	0.0116	0.0116	CcSEcCtD
Aztreonam—Anaemia—Thalidomide—leprosy	0.0115	0.0115	CcSEcCtD
Aztreonam—Angioedema—Thalidomide—leprosy	0.0114	0.0114	CcSEcCtD
Aztreonam—Malaise—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Aztreonam—Vertigo—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Aztreonam—Cough—Thalidomide—leprosy	0.0109	0.0109	CcSEcCtD
Aztreonam—Convulsion—Thalidomide—leprosy	0.0108	0.0108	CcSEcCtD
Aztreonam—Chest pain—Thalidomide—leprosy	0.0106	0.0106	CcSEcCtD
Aztreonam—Myalgia—Thalidomide—leprosy	0.0106	0.0106	CcSEcCtD
Aztreonam—Discomfort—Thalidomide—leprosy	0.0105	0.0105	CcSEcCtD
Aztreonam—Confusional state—Thalidomide—leprosy	0.0102	0.0102	CcSEcCtD
Aztreonam—Thrombocytopenia—Thalidomide—leprosy	0.00995	0.00995	CcSEcCtD
Aztreonam—Hyperhidrosis—Thalidomide—leprosy	0.00982	0.00982	CcSEcCtD
Aztreonam—Hypotension—Thalidomide—leprosy	0.0095	0.0095	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Thalidomide—leprosy	0.00926	0.00926	CcSEcCtD
Aztreonam—Insomnia—Thalidomide—leprosy	0.00919	0.00919	CcSEcCtD
Aztreonam—Paraesthesia—Thalidomide—leprosy	0.00913	0.00913	CcSEcCtD
Aztreonam—Dyspnoea—Thalidomide—leprosy	0.00906	0.00906	CcSEcCtD
Aztreonam—Pain—Thalidomide—leprosy	0.00869	0.00869	CcSEcCtD
Aztreonam—Feeling abnormal—Thalidomide—leprosy	0.00837	0.00837	CcSEcCtD
Aztreonam—Gastrointestinal pain—Thalidomide—leprosy	0.00831	0.00831	CcSEcCtD
Aztreonam—Urticaria—Thalidomide—leprosy	0.00807	0.00807	CcSEcCtD
Aztreonam—Abdominal pain—Thalidomide—leprosy	0.00803	0.00803	CcSEcCtD
Aztreonam—Body temperature increased—Thalidomide—leprosy	0.00803	0.00803	CcSEcCtD
Aztreonam—Hypersensitivity—Thalidomide—leprosy	0.00749	0.00749	CcSEcCtD
Aztreonam—Asthenia—Thalidomide—leprosy	0.00729	0.00729	CcSEcCtD
Aztreonam—Pruritus—Thalidomide—leprosy	0.00719	0.00719	CcSEcCtD
Aztreonam—Diarrhoea—Thalidomide—leprosy	0.00695	0.00695	CcSEcCtD
Aztreonam—Dizziness—Thalidomide—leprosy	0.00672	0.00672	CcSEcCtD
Aztreonam—Vomiting—Thalidomide—leprosy	0.00646	0.00646	CcSEcCtD
Aztreonam—Rash—Thalidomide—leprosy	0.00641	0.00641	CcSEcCtD
Aztreonam—Dermatitis—Thalidomide—leprosy	0.0064	0.0064	CcSEcCtD
Aztreonam—Headache—Thalidomide—leprosy	0.00637	0.00637	CcSEcCtD
Aztreonam—Nausea—Thalidomide—leprosy	0.00604	0.00604	CcSEcCtD
